Gigliotti et al., 2025): Adapt to changing hunger cues and find a sustainable eating rhythm Manage GI symptoms through pacing, hydration, and fiber adjustments Understand the importance of resistance exercise and protein intake to preserve muscle mass and prevent excessive metabolic slowdown Stay nourished while balancing medication side effects and real-life routines Regular follow-up is key
You should talk to your doctor about your own risk
Apoyo en Control de Peso: Excelente aliado en dietas de adelgazamiento y definicin muscular
Compared to the control group, GLP-1RAs were associated with significant reductions in weight (mean difference (MD) = -5.70 kg, 95% confidence interval (CI): -9.52 to -1.88), BMI (MD = -2.94 kg/m 2 , 95% CI: -5.60 to -0.28), WC (MD = -3.66 cm, 95% CI: -4.89 to -2.43), glycated hemoglobin A1c (HbA1c) (standardized mean difference (SMD) = -0.73, 95% CI: -1.14 to -0.32), and systolic blood pressure (SBP) (MD = -3.62 mm Hg, 95% CI: -5.51 to -1.73) after cessation of therapy
Understanding how this medication works in your body, what occurs after discontinuation, and how to sustain results helps you make informed decisions about your treatment
The ACR Convergence 2025 data, the Sjogren case report, the CRP reduction data from STEP and SELECT trials